TAMMY CHAUNDY: Open Payments
NPI 1932518941 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,343 in 67 payments from 16 companies in 2025. Trend: 2023 $1,696 · 2024 $2,085 · 2025 $1,343
Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $403 |
| Janssen Biotech, Inc. | 10 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| GENZYME CORPORATION | 4 | $111 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Aimmune Therapeutics, Inc. | 2 | $64 |
| Madrigal Pharmaceuticals | 2 | $61 |
| Ardelyx, Inc. | 2 | $41 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
Products named: DUPIXENT, RINVOQ, TREMFYA, CREON, XIFAXAN, ENTYVIO, REZDIFFRA, IBSRELA.
Industry payments across FL — which companies pay providers there.
